2seventy bio Inc (TSVT)
4.23
-0.13
(-2.98%)
USD |
NASDAQ |
May 31, 16:00
4.23
0.00 (0.00%)
After-Hours: 20:00
2seventy bio SG&A Expense (Annual): 69.41M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 69.41M |
December 31, 2022 | 79.45M |
December 31, 2021 | 93.51M |
Date | Value |
---|---|
December 31, 2020 | 90.90M |
December 31, 2019 | 81.65M |
December 31, 2018 | 53.63M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
69.41M
Minimum
2023
93.51M
Maximum
2021
82.98M
Average
81.65M
Median
2019
SG&A Expense (Annual) Benchmarks
Bristol-Myers Squibb Co | 7.772B |
Johnson & Johnson | 20.11B |
Macrogenics Inc | 52.19M |
Akebia Therapeutics Inc | 100.23M |
Tango Therapeutics Inc | 35.50M |